Christina Karamboulas

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

MicroRNA-mediated PTEN downregulation as a novel non-genetic mechanism of acquired resistance to PI3Kα inhibitors of head & neck squamous cell carcinoma.

MicroRNA-mediated PTEN downregulation as a novel non-genetic mechanism of acquired resistance to PI3Kα inhibitors of head & neck squamous cell carcinoma.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: February 06, 2025

Pan-cancer N-glycoproteomic atlas of patient-derived xenografts uncovers FAT2 as an actionable surface target.

Pan-cancer N-glycoproteomic atlas of patient-derived xenografts uncovers FAT2 as an actionable surface target.

Journal: Cell reports. Medicine

Published: January 09, 2025

Molecular correlates for HPV-negative head and neck cancer engraftment prognosticate patient outcomes.

Molecular correlates for HPV-negative head and neck cancer engraftment prognosticate patient outcomes.

Journal: Nature communications

Published: May 02, 2024

PRMT1 inhibition perturbs RNA metabolism and induces DNA damage in clear cell renal cell carcinoma.

PRMT1 inhibition perturbs RNA metabolism and induces DNA damage in clear cell renal cell carcinoma.

Journal: Nature communications

Published: April 13, 2023

Extracellular Heparan 6-O-Endosulfatases SULF1 and SULF2 in Head and Neck Squamous Cell Carcinoma and Other Malignancies.

Extracellular Heparan 6-O-Endosulfatases SULF1 and SULF2 in Head and Neck Squamous Cell Carcinoma and Other Malignancies.

Journal: Cancers

Published: October 10, 2022

Development and Validation of an Oral Cavity Cancer Outcomes Prediction Score Incorporating Patient-Derived Xenograft Engraftment.

Development and Validation of an Oral Cavity Cancer Outcomes Prediction Score Incorporating Patient-Derived Xenograft Engraftment.

Journal: JAMA otolaryngology-- head & neck surgery

Published: March 03, 2022

Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement.

Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement.

Journal: Cancer

Published: December 14, 2020

Establishment and Use of Patient-Derived Xenograft Models for Drug Testing in Head and Neck Squamous Cell Carcinoma.

Establishment and Use of Patient-Derived Xenograft Models for Drug Testing in Head and Neck Squamous Cell Carcinoma.

Journal: STAR protocols

Published: October 28, 2020

PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell Carcinoma.

PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell Carcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 29, 2019

Distinct fibroblast functional states drive clinical outcomes in ovarian cancer and are regulated by TCF21.

Distinct fibroblast functional states drive clinical outcomes in ovarian cancer and are regulated by TCF21.

Journal: The Journal of experimental medicine

Published: June 17, 2019

Patient-derived xenografts: a promising resource for preclinical cancer research.

Patient-derived xenografts: a promising resource for preclinical cancer research.

Journal: Molecular & cellular oncology

Published: November 28, 2018

Patient-Derived Xenografts for Prognostication and Personalized Treatment for Head and Neck Squamous Cell Carcinoma.

Patient-Derived Xenografts for Prognostication and Personalized Treatment for Head and Neck Squamous Cell Carcinoma.

Journal: Cell reports

Published: November 13, 2017

Showing 1-12 of 17

Last Updated: 09/26/2026